Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kira Flaherty
Inhibition of HGF/MET Signaling Decreases Overall Tumor Burden and Blocks Malignant Conversion in Tpl2-Related Skin Cancer
Oncogenesis
Cancer Research
Molecular Biology
Related publications
HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling
Cancers
Cancer Research
Oncology
Mechanisms of HGF/Met Signaling to BRK and Sam68 in Breast Cancer Progression
Hormones and Cancer
Oncology
Cancer Research
Endocrinology
Autonomic Systems
Endocrine
Metabolism
Diabetes
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage Over Inhibiting HGF/MET Signaling
Cancer Research
Cancer Research
Oncology
Inhibition of NF-kappa B Activity in Mammary Epithelium Increases Tumor Latency and Decreases Tumor Burden
Oncogene
Cancer Research
Genetics
Molecular Biology
The Persistent Promise of Combining HGF/MET and EGFR Inhibition in Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
MAP Kinase Kinase Kinase 8 (MAP3K8; COT; TPL2); C-Met Proto-Oncogene (MET; HGFR); Hepatocyte Growth Factor/Scatter Factor (HGF/SF)
Science-Business eXchange
Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reducing Overall Tumor Burden
Surgery
Surgery
Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
HGF/c-Met Axis Drives Cancer Aggressiveness in the Neoadjuvant Setting of Ovarian Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics